Titre : Graphite

Graphite : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reproducibility of Results
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Graphite : Questions médicales les plus fréquentes", "headline": "Graphite : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Graphite : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-29", "dateModified": "2025-02-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Graphite" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Minéraux", "url": "https://questionsmedicales.fr/mesh/D008903", "about": { "@type": "MedicalCondition", "name": "Minéraux", "code": { "@type": "MedicalCode", "code": "D008903", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D01.578" } } }, "about": { "@type": "MedicalCondition", "name": "Graphite", "alternateName": "Graphite", "code": { "@type": "MedicalCode", "code": "D006108", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Wei Chen", "url": "https://questionsmedicales.fr/author/Wei%20Chen", "affiliation": { "@type": "Organization", "name": "Institute of Medical Engineering, Department of Biophysics, School of Basic Medical Sciences, Health Science Center, Xi'an Jiaotong University Xi'an 710061 China wuchunsheng@xjtu.edu.cn +86-29-82657763 +86-29-82657763." } }, { "@type": "Person", "name": "Nan Jiang", "url": "https://questionsmedicales.fr/author/Nan%20Jiang", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Marine Materials and Related Technologies, Zhejiang Key Laboratory of Marine Materials and Protective Technologies, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China." } }, { "@type": "Person", "name": "Jian Duan", "url": "https://questionsmedicales.fr/author/Jian%20Duan", "affiliation": { "@type": "Organization", "name": "Institute of New Energy for Vehicles, School of Materials Science and Engineering, Tongji University, Shanghai 201804, China." } }, { "@type": "Person", "name": "Wei Luo", "url": "https://questionsmedicales.fr/author/Wei%20Luo", "affiliation": { "@type": "Organization", "name": "Institute of New Energy for Vehicles, School of Materials Science and Engineering, Tongji University, Shanghai 201804, China." } }, { "@type": "Person", "name": "Tengrui Wang", "url": "https://questionsmedicales.fr/author/Tengrui%20Wang", "affiliation": { "@type": "Organization", "name": "Institute of New Energy for Vehicles, School of Materials Science and Engineering, Tongji University, Shanghai 201804, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Development and Initial Psychometric Validation of the COVID-19 Pandemic Burden Index for Healthcare Workers.", "datePublished": "2023-01-18", "url": "https://questionsmedicales.fr/article/36652099", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11606-023-08028-3" } }, { "@type": "ScholarlyArticle", "name": "Prediction of surfactin fermentation with Bacillus subtilis DSM10 by response surface methodology optimized artificial neural network.", "datePublished": "2023-01-18", "url": "https://questionsmedicales.fr/article/36655349", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cbf.3776" } }, { "@type": "ScholarlyArticle", "name": "Importance of Social Support of Parents of Children with Cancer: A Multicomponent Model Using Partial Least Squares-Path Modelling.", "datePublished": "2023-01-18", "url": "https://questionsmedicales.fr/article/36767137", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20031757" } }, { "@type": "ScholarlyArticle", "name": "Nonsteroidal anti-inflammatory drug monitoring in serum: a Tb-MOF-based luminescent mixed matrix membrane detector with high sensitivity and reliability.", "datePublished": "2023-01-17", "url": "https://questionsmedicales.fr/article/36533903", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d2dt03426c" } }, { "@type": "ScholarlyArticle", "name": "Provider- and Facility-Level Variation in Precancerous Cervical Biopsy Diagnoses.", "datePublished": "2023-01-17", "url": "https://questionsmedicales.fr/article/36728078", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/LGT.0000000000000721" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Produits chimiques inorganiques", "item": "https://questionsmedicales.fr/mesh/D007287" }, { "@type": "ListItem", "position": 3, "name": "Minéraux", "item": "https://questionsmedicales.fr/mesh/D008903" }, { "@type": "ListItem", "position": 4, "name": "Graphite", "item": "https://questionsmedicales.fr/mesh/D006108" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Graphite - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Graphite", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Graphite", "description": "Comment diagnostiquer une exposition au graphite ?\nQuels tests sont utilisés pour évaluer les effets du graphite ?\nQuels symptômes indiquent une intoxication au graphite ?\nLe graphite peut-il être détecté dans le sang ?\nQuels professionnels peuvent diagnostiquer une exposition au graphite ?", "url": "https://questionsmedicales.fr/mesh/D006108?mesh_terms=Reproducibility+of+Results&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Graphite", "description": "Quels sont les symptômes d'une exposition prolongée au graphite ?\nLe graphite peut-il causer des problèmes respiratoires ?\nY a-t-il des symptômes neurologiques liés au graphite ?\nComment le graphite affecte-t-il la peau ?\nLes symptômes d'exposition au graphite sont-ils immédiats ?", "url": "https://questionsmedicales.fr/mesh/D006108?mesh_terms=Reproducibility+of+Results&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Graphite", "description": "Comment prévenir l'exposition au graphite au travail ?\nQuelles mesures de sécurité doivent être prises lors de la manipulation du graphite ?\nLes travailleurs doivent-ils être formés sur les risques du graphite ?\nY a-t-il des réglementations concernant l'utilisation du graphite ?\nComment réduire l'exposition au graphite dans les environnements domestiques ?", "url": "https://questionsmedicales.fr/mesh/D006108?mesh_terms=Reproducibility+of+Results&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Graphite", "description": "Quel traitement est recommandé pour l'intoxication au graphite ?\nDes médicaments sont-ils nécessaires pour traiter l'exposition au graphite ?\nComment traiter les irritations cutanées causées par le graphite ?\nLe traitement des problèmes respiratoires liés au graphite est-il différent ?\nQuand consulter un médecin après une exposition au graphite ?", "url": "https://questionsmedicales.fr/mesh/D006108?mesh_terms=Reproducibility+of+Results&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Graphite", "description": "Quelles complications peuvent survenir après une exposition au graphite ?\nLe graphite peut-il causer des maladies pulmonaires ?\nY a-t-il des risques de cancer liés au graphite ?\nComment les complications liées au graphite sont-elles traitées ?\nLes complications sont-elles réversibles après l'arrêt de l'exposition ?", "url": "https://questionsmedicales.fr/mesh/D006108?mesh_terms=Reproducibility+of+Results&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Graphite", "description": "Qui est le plus à risque d'exposition au graphite ?\nL'âge influence-t-il le risque d'exposition au graphite ?\nLes fumeurs sont-ils plus à risque d'effets du graphite ?\nY a-t-il des prédispositions génétiques aux effets du graphite ?\nLes personnes ayant des antécédents médicaux sont-elles plus à risque ?", "url": "https://questionsmedicales.fr/mesh/D006108?mesh_terms=Reproducibility+of+Results&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une exposition au graphite ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic peut inclure des tests sanguins et des évaluations cliniques des symptômes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les effets du graphite ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire et des radiographies peuvent être effectués." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication au graphite ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des difficultés respiratoires, des irritations cutanées et des maux de tête." } }, { "@type": "Question", "name": "Le graphite peut-il être détecté dans le sang ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des analyses spécifiques peuvent détecter des particules de graphite dans le sang." } }, { "@type": "Question", "name": "Quels professionnels peuvent diagnostiquer une exposition au graphite ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les médecins du travail et les spécialistes en toxicologie sont compétents pour ce diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une exposition prolongée au graphite ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux, essoufflement et irritation des yeux et de la peau." } }, { "@type": "Question", "name": "Le graphite peut-il causer des problèmes respiratoires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inhalation de particules de graphite peut entraîner des problèmes respiratoires." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques liés au graphite ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des maux de tête et des vertiges peuvent survenir en cas d'exposition élevée." } }, { "@type": "Question", "name": "Comment le graphite affecte-t-il la peau ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Le contact avec le graphite peut provoquer des irritations cutanées et des éruptions." } }, { "@type": "Question", "name": "Les symptômes d'exposition au graphite sont-ils immédiats ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître immédiatement ou se développer avec le temps." } }, { "@type": "Question", "name": "Comment prévenir l'exposition au graphite au travail ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et assurer une ventilation adéquate." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être prises lors de la manipulation du graphite ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Porter des gants, des masques et des lunettes de protection pour éviter l'exposition." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés sur les risques du graphite ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle." } }, { "@type": "Question", "name": "Y a-t-il des réglementations concernant l'utilisation du graphite ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réglementations existent pour limiter l'exposition au graphite dans l'industrie." } }, { "@type": "Question", "name": "Comment réduire l'exposition au graphite dans les environnements domestiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'utilisation de produits contenant du graphite et assurer une bonne ventilation." } }, { "@type": "Question", "name": "Quel traitement est recommandé pour l'intoxication au graphite ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste principalement à éliminer l'exposition et à gérer les symptômes." } }, { "@type": "Question", "name": "Des médicaments sont-ils nécessaires pour traiter l'exposition au graphite ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anti-inflammatoires peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "Comment traiter les irritations cutanées causées par le graphite ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des crèmes apaisantes et des antihistaminiques peuvent être utilisés pour soulager l'irritation." } }, { "@type": "Question", "name": "Le traitement des problèmes respiratoires liés au graphite est-il différent ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bronchodilatateurs et des corticostéroïdes peuvent être nécessaires." } }, { "@type": "Question", "name": "Quand consulter un médecin après une exposition au graphite ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de consulter un médecin si des symptômes persistent ou s'aggravent." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une exposition au graphite ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications respiratoires chroniques et des problèmes dermatologiques peuvent survenir." } }, { "@type": "Question", "name": "Le graphite peut-il causer des maladies pulmonaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition prolongée peut entraîner des maladies pulmonaires comme la pneumoconiose." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer liés au graphite ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien potentiel entre l'exposition au graphite et certains cancers." } }, { "@type": "Question", "name": "Comment les complications liées au graphite sont-elles traitées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend des complications, incluant des soins respiratoires et dermatologiques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles après l'arrêt de l'exposition ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition au graphite ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans les industries de la fabrication et de la construction sont les plus à risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'exposition au graphite ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs plus âgés peuvent avoir un risque accru en raison d'une exposition prolongée." } }, { "@type": "Question", "name": "Les fumeurs sont-ils plus à risque d'effets du graphite ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut aggraver les effets respiratoires liés à l'exposition au graphite." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques aux effets du graphite ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des prédispositions génétiques peuvent influencer la susceptibilité aux effets du graphite." } }, { "@type": "Question", "name": "Les personnes ayant des antécédents médicaux sont-elles plus à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec des antécédents respiratoires ou dermatologiques sont plus vulnérables." } } ] } ] }

Sources (10000 au total)

Development and Initial Psychometric Validation of the COVID-19 Pandemic Burden Index for Healthcare Workers.

The burden of COVID-19 on healthcare workers (HCWs) is reported to be increasing, yet the psychometric scales now in use evaluate only single aspects; few measure the pandemic-specific burden on HCWs ... To develop a scale to quantify the physical, mental, and socioeconomic burden of the COVID-19 pandemic on HCWs.... Scale development and cross-sectional survey.... Consenting HCWs aged ≥20.... Development of an item-list based on literature reviews and HCW panel input, evaluation of content validity and item selection using the Delphi method, psychometric testing conducted on HCWs, validity... Through the Delphi process, a 29-item pilot scale was generated. In psychometric testing, data from 863 HCWs contributed to the development of the final version of this scale, called Pandemic Burden I... The psychometrically sound questionnaire we developed to measure pandemic-specific burdens for HCWs provides an understanding of comprehensive burdens on HCWs and may serve to evaluate interventions t...

Nonsteroidal anti-inflammatory drug monitoring in serum: a Tb-MOF-based luminescent mixed matrix membrane detector with high sensitivity and reliability.

The identification of drugs or biomolecules for public health monitoring requires facile analytical technologies with excellent sensitivity, portability and reliability. In the past decades, different...

Provider- and Facility-Level Variation in Precancerous Cervical Biopsy Diagnoses.

Reproducibility of cervical biopsy diagnoses is low and may vary based on where the diagnostic test is performed and by whom. Our objective was to measure multilevel variation in diagnoses across colp... We cross-sectionally examined variation in cervical biopsy diagnoses within the 5 sites of the Population-Based Research Optimizing Screening through Personalized Regimens (PROSPR I) consortium within... A total of 130,110 patients were included who received care across 82 laboratory facilities, 2,620 colposcopists, and 489 pathologists. Substantial variation in biopsy diagnoses was found at each leve... Improving consistency in cervical biopsy diagnoses is needed to reduce underdiagnosis, overdiagnosis, and unnecessary treatment resulting from variation in cervical biopsy diagnoses....

A signature of immune-related genes correlating with clinical prognosis and immune microenvironment in sepsis.

Immune-related genes (IRGs) remain poorly understood in their function in the onset and progression of sepsis.... GSE65682 was obtained from the Gene Expression Omnibus database. The IRGs associated with survival were screened for subsequent modeling using univariate Cox regression analysis and least absolute shr... Based on 7 IRGs signature, patients could be separated into low-risk and high-risk groups. Patients in the low-risk group had a remarkably increased 28-day survival compared to those in the high-risk ... We developed a 7 IRGs signature as a novel prognostic marker for predicting sepsis patients' 28-day survival, indicating possibilities for individualized reasonable resource distribution of intensive ...

Towards an understanding of help-seeking behaviour for disordered eating: Refinement of a barriers to help-seeking measure.

Early intervention in eating disorders (EDs) is hampered by a lack of validated measures of barriers to treatment seeking. The present study examined the factor structure of the Perceived Barriers to ... Participants were 456 female university students aged 17-25 reporting a wide range of disordered eating severity. Confirmatory factor analyses were conducted with the whole sample followed by correlat... Four models were tested. First, we replicated the original PBPT 8-factor structure in our sample with comparable fit indices. Second, the addition of six ED items comprising a Denial and Ambivalence s... While the present study contributes to refining the assessment of barriers to help-seeking, future studies should consider co-design with lived experience to further improve the model fit of the quest...